Clinical Trials Logo

Clinical Trial Summary

This research is conducted with the aim of improving the quality of life of laryngectomized patients and their entourage. Worldwide, there are 185,000 new cases of laryngeal cancer per year. In Europe, between 2000 and 2007, the crude annual incidence rates of these cancers were 4.6/100,000 with a 5-year survival rate of 61%. In France, about 30 to 35% of cancers of the upper aerodigestive tract are localized to the larynx, or about 43,000 cases per year. Most patients are men (89%) between 50 and 70 years old. One of the treatments for these cancers is to perform an excision of the larynx thus removing the entire tumor, it is the total laryngectomy. The trachea is thus permanently removed from the skin and the digestive tract becomes independent.


Clinical Trial Description

In the ENT department of Bichat Hospital, there is an average of fourteen surgeries of this type per year, over the last three years. The direct consequences of total laryngectomy are multiple: - loss of phonation (voice) and need to learn to speak again through speech therapy; - Disappearance of oral-nasal breathing (and therefore loss of smell, or even taste); - Disappearance of the capacity of the effort with closed glottis (used in the acts of daily life: defecation, sexual act in men, etc.); - Impairment of body image and sometimes self-esteem. For these reasons, it is essential to accompany patients post-operative to help them understand their body image and mitigate the direct and indirect consequences of this intervention. There are very few organizations to assist these patients in this life change. To support laryngectomized patients, the study will test and validate the creation of self-help and support groups. The study will include laryngectomized patients who wish and can participate in these groups. The sessions will take place as follows: - 1st: presentation of each, answers to questions; - 2nd: intervention of the association of the mutilated of the voice; - 3rd: questions / answers with a resource patient (laryngectomized for 13 years in Bichat); - 4th: grouping of all participants to assess patient satisfaction. To assess the benefit of these meetings, a global quality of life questionnaire (WHOQOL-BREF) and an ENT-specific questionnaire (EORTC QLQH&n43) will be given to patients before the first session and retrieved beforehand. The patient will be able to participate in the sessions only if the questionnaires are submitted. The questionnaires are accompanied by a free text part, so that the person fills in the keys that the workshops have brought him. Patients who cannot participate in the exchange groups for geographical or personal reasons will constitute a control group. They will also complete the two questionnaires four months apart. The number of patients registered and the participation rate at each session will be evaluated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06077643
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Angèle Germon
Phone 06.40.65.58.75
Email angele.germon@aphp.fr
Status Recruiting
Phase
Start date October 10, 2023
Completion date October 10, 2024

See also
  Status Clinical Trial Phase
Completed NCT01089803 - Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer N/A
Completed NCT00026975 - Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients Phase 2
Completed NCT01435252 - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab Phase 2
Recruiting NCT04174950 - Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients N/A
Recruiting NCT05857202 - Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
Not yet recruiting NCT06137378 - European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] Phase 2
Active, not recruiting NCT02586207 - Pembrolizumab in Combination With CRT for LA-SCCHN Phase 1
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Recruiting NCT05375266 - Immune Biomarker Study for Head and Neck Cancer
Completed NCT03134976 - Wound Complications in Head and Neck Surgery
Recruiting NCT04650919 - Aortic Laryngeal Rehabilitation Graft N/A
Recruiting NCT05830240 - A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer Early Phase 1
Terminated NCT02437513 - NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration N/A
Completed NCT01633541 - Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer Phase 2
Completed NCT01332682 - Resistance Training and Physical Functioning in Head and Neck Cancer Patients Phase 1
Terminated NCT00011492 - Patient Evaluation for Head and Neck Surgery Branch Studies
Recruiting NCT05349487 - SpeakFree Heat and Moisture Exchanger (HME) N/A
Completed NCT00467948 - Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients Phase 3
Recruiting NCT06024980 - Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy N/A
Recruiting NCT03747783 - Nomograms to Precisely Predict Conditional Risk of Survival for Patients With Laryngeal Cancer